Cotter, Pete

Pete Cotter
Associate Director, Analytical Development

Pete Cotter is the associate director, analytical development at Verve Therapeutics. He is a biotechnology industry veteran, with over 15 years of drug development experience across multiple therapeutic modalities.  Prior to joining Verve, he worked as the associate director of the drug product analytical development group at Vor Biopharma, overseeing the development and implementation of analytical characterization assays for both CAR-T and gene-edited HSPC gene therapies. Previously, he also worked at CRISPR Therapeutics, where he helped establish the analytical development group and supported several INDs for CRISPR edited HSPC and CAR-T gene therapy products. Pete received his BA in agriculture and applied economics and his MS in animal science-physiology at Texas Tech University.